Detalles de la búsqueda
1.
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Br J Haematol
; 196(4): 892-901, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34761389
2.
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
Lancet
; 395(10241): 1919-1926, 2020 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32473682
3.
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306).
Br J Haematol
; 188(2): 240-248, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879945
4.
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma.
Ann Hematol
; 99(12): 2837-2846, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314038
5.
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors.
Support Care Cancer
; 27(7): 2569-2577, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30443809
6.
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.
N Engl J Med
; 372(17): 1598-607, 2015 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25901426
7.
Enhanced formation of giant cells in common variable immunodeficiency: Relation to granulomatous disease.
Clin Immunol
; 175: 1-9, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27856306
8.
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline.
Br J Haematol
; 196(3): 507-522, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811725
9.
Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B-cell non-Hodgkin lymphoma: post-hoc analyses from a phase III trial.
Br J Haematol
; 174(5): 692-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118109
10.
Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.
Br J Haematol
; 173(2): 274-82, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26849853
11.
Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.
Future Oncol
; 12(15): 1759-68, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27093976
12.
Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.
Support Care Cancer
; 24(6): 2677-84, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26780505
13.
Characterization of bone marrow mesenchymal stromal cells in aplastic anaemia.
Br J Haematol
; 169(6): 804-13, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819548
14.
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.
Breast Cancer Res Treat
; 152(1): 67-76, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26017071
15.
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.
Support Care Cancer
; 23(2): 525-45, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25284721
16.
Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors.
BMC Cancer
; 14: 201, 2014 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24641830
17.
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
Br J Haematol
; 181(4): 555-559, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28342183
18.
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial.
Lancet Oncol
; 13(7): 696-706, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22652183
19.
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.
Blood
; 116(16): 3080-8, 2010 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20587785
20.
Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice.
BMC Cancer
; 12: 362, 2012 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22913768